Pfizer COVID-19 vaccine entering final phase of review in U.S.

Pfizer COVID-19 vaccine entering final phase of review in U.S.

With the U.S. potentially just days away from the distribution of a coronavirus vaccine, top health officials are painting a dire picture of the country's case count and hospitalizations in the coming months. Dr. Neeta Ogden, an internal medicine specialist and immunologist, joined CBSN to discuss the vaccines being prepared around the world.